Latest Funding News

Perpetual Resources has raised $1.6 million to accelerate exploration of lithium and caesium deposits in Brazil, following promising initial drilling results at its Igrejinha project.

Macro Metals Limited has successfully raised A$2 million through a share placement, positioning itself to accelerate exploration and expand its mining services operations.

SRJ Technologies has secured $1.38 million from institutional investors in a fully underwritten entitlement offer, setting the stage for a strategic joint venture and acquisition in the Middle East. The company aims to raise an additional $1.15 million through a retail offer to support its growth ambitions.

Platinum Investment Management has officially terminated its Scheme Implementation Deed with Platinum Capital Limited, marking a significant shift in the management of the Platinum International Fund Complex ETF.

Caprice Resources has confirmed further high-grade gold intercepts and new mineralised zones at its Island Gold Project, extending known mineralisation and boosting confidence ahead of a fully funded Phase 4 drilling campaign.

HeraMED Limited has resumed trading on the ASX following the release of its quarterly reports and a significant capital raising announcement, marking a pivotal moment for the medical device company.

Nimy Resources has appointed NYSE-listed M2i Global to spearhead its US government funding strategy, targeting key grants and loans to advance its gallium projects. This partnership aligns Nimy with critical supply chain initiatives in the United States.

Hot Chili Limited has announced a non-renounceable entitlement offer aiming to raise approximately A$14 million to advance its strategic partnering efforts and drilling programs. Eligible shareholders can subscribe for new shares at 60 cents each, with funds earmarked for exploration and corporate purposes.

FireFly Metals has secured environmental approval and reported exceptional metallurgical results for its Green Bay Copper-Gold Project in Canada, setting the stage for a production restart. With economic studies underway and strong funding, the project is rapidly advancing toward a scoping study release in early 2026.

Platinum Capital Limited has pulled its proposed scheme of arrangement due to insufficient shareholder support but will proceed with an on-market buy-back. Meanwhile, L1 Capital pushes for management control and board renewal.

Vitrafy Life Sciences reported strong FY25 progress with 75% sales growth, advanced cryopreservation technology development, and a robust cash position. The company outlines a clear commercialisation roadmap for FY26, including product launches and expanded U.S. operations.

Vitrafy Life Sciences reported a $32.7 million loss for FY25, driven by investments in its next-generation cryopreservation platform following a $35 million IPO and a $4.8 million government grant. The company is progressing commercialization efforts with key partnerships in human and animal health.